The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.
Insights and Analysis
Also in this roundup of hospital and health system leadership changes: Carson Tahoe Health, Carson City, Nev., appoints CEO; and HCA Houston Healthcare…
Together, we have a chance to design coordinated systems of support for patients and their families – next-generation care that will build a nation of…
The Arizona Hospital and Healthcare Association yesterday named Ann-Marie Alameddin as its president and CEO effective April 2.
I was pleased to take part in a robust discussion about new leadership competencies last week in conjunction with the South by Southwest Festival.
As more female physicians enter the workforce and face challenges that can lead to burnout, the AHA has joined with five medical organizations to bring…
The AHA is here to help hospitals and health systems build the future of health care delivery.